vs
安捷伦科技（A）与WESTERN ALLIANCE BANCORPORATION（WAL）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是WESTERN ALLIANCE BANCORPORATION的1.8倍（$1.8B vs $1.0B），WESTERN ALLIANCE BANCORPORATION净利率更高（18.6% vs 17.0%，领先1.6%），WESTERN ALLIANCE BANCORPORATION同比增速更快（31.0% vs 7.0%），过去两年WESTERN ALLIANCE BANCORPORATION的营收复合增速更高（14.9% vs 6.9%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
Western Alliance Bancorporation是总部位于美国菲尼克斯的区域性银行控股公司，长期深耕美国本土区域金融服务市场，目前已跻身美国最大银行行列，在福布斯发布的美国最佳银行榜单中排名第97位。
A vs WAL — 直观对比
营收规模更大
A
是对方的1.8倍
$1.0B
营收增速更快
WAL
高出24.0%
7.0%
净利率更高
WAL
高出1.6%
17.0%
两年增速更快
WAL
近两年复合增速
6.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.0B |
| 净利润 | $305.0M | $189.2M |
| 毛利率 | 52.6% | — |
| 营业利润率 | 19.6% | — |
| 净利率 | 17.0% | 18.6% |
| 营收同比 | 7.0% | 31.0% |
| 净利润同比 | -4.1% | -5.0% |
| 每股收益（稀释后） | $1.07 | $1.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AWAL
| Q1 26 | $1.8B | $1.0B | ||
| Q4 25 | $1.9B | $980.9M | ||
| Q3 25 | $1.7B | $938.2M | ||
| Q2 25 | $1.7B | $845.9M | ||
| Q1 25 | $1.7B | $778.0M | ||
| Q4 24 | $1.7B | $838.4M | ||
| Q3 24 | $1.6B | $823.1M | ||
| Q2 24 | $1.6B | $771.8M |
净利润AWAL
| Q1 26 | $305.0M | $189.2M | ||
| Q4 25 | $434.0M | $286.1M | ||
| Q3 25 | $336.0M | $253.4M | ||
| Q2 25 | $215.0M | $230.4M | ||
| Q1 25 | $318.0M | $199.1M | ||
| Q4 24 | $351.0M | $216.9M | ||
| Q3 24 | $282.0M | $199.8M | ||
| Q2 24 | $308.0M | $193.6M |
毛利率AWAL
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
营业利润率AWAL
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 36.3% | ||
| Q3 25 | 20.7% | 33.4% | ||
| Q2 25 | 18.0% | 34.4% | ||
| Q1 25 | 22.4% | 31.7% | ||
| Q4 24 | 24.0% | 30.9% | ||
| Q3 24 | 21.1% | 30.6% | ||
| Q2 24 | 23.1% | 32.1% |
净利率AWAL
| Q1 26 | 17.0% | 18.6% | ||
| Q4 25 | 23.3% | 29.2% | ||
| Q3 25 | 19.3% | 27.0% | ||
| Q2 25 | 12.9% | 27.2% | ||
| Q1 25 | 18.9% | 25.6% | ||
| Q4 24 | 20.6% | 25.9% | ||
| Q3 24 | 17.9% | 24.3% | ||
| Q2 24 | 19.6% | 25.1% |
每股收益（稀释后）AWAL
| Q1 26 | $1.07 | $1.65 | ||
| Q4 25 | $1.53 | $2.59 | ||
| Q3 25 | $1.18 | $2.28 | ||
| Q2 25 | $0.75 | $2.07 | ||
| Q1 25 | $1.11 | $1.79 | ||
| Q4 24 | $1.23 | $1.94 | ||
| Q3 24 | $0.97 | $1.80 | ||
| Q2 24 | $1.05 | $1.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | — |
| 总债务越低越好 | $3.0B | $4.3B |
| 股东权益账面价值 | $6.9B | $7.9B |
| 总资产 | $12.8B | $98.9B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.54× |
8季度趋势，按日历期对齐
现金及短期投资AWAL
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.7B | — |
总债务AWAL
| Q1 26 | $3.0B | $4.3B | ||
| Q4 25 | $3.0B | $1.4B | ||
| Q3 25 | $3.4B | $2.9B | ||
| Q2 25 | $3.3B | $2.9B | ||
| Q1 25 | $3.3B | $1.6B | ||
| Q4 24 | $3.3B | $2.4B | ||
| Q3 24 | $2.1B | $1.4B | ||
| Q2 24 | $2.1B | $436.0M |
股东权益AWAL
| Q1 26 | $6.9B | $7.9B | ||
| Q4 25 | $6.7B | $7.7B | ||
| Q3 25 | $6.4B | $7.4B | ||
| Q2 25 | $6.1B | $7.1B | ||
| Q1 25 | $6.0B | $6.9B | ||
| Q4 24 | $5.9B | $6.7B | ||
| Q3 24 | $5.9B | $6.7B | ||
| Q2 24 | $6.2B | $6.3B |
总资产AWAL
| Q1 26 | $12.8B | $98.9B | ||
| Q4 25 | $12.7B | $92.8B | ||
| Q3 25 | $12.2B | $91.0B | ||
| Q2 25 | $12.2B | $86.7B | ||
| Q1 25 | $11.9B | $83.0B | ||
| Q4 24 | $11.8B | $80.9B | ||
| Q3 24 | $11.0B | $80.1B | ||
| Q2 24 | $10.9B | $80.6B |
负债/权益比AWAL
| Q1 26 | 0.44× | 0.54× | ||
| Q4 25 | 0.45× | 0.18× | ||
| Q3 25 | 0.53× | 0.39× | ||
| Q2 25 | 0.55× | 0.41× | ||
| Q1 25 | 0.56× | 0.23× | ||
| Q4 24 | 0.57× | 0.36× | ||
| Q3 24 | 0.36× | 0.21× | ||
| Q2 24 | 0.34× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | — |
| 自由现金流经营现金流 - 资本支出 | $175.0M | — |
| 自由现金流率自由现金流/营收 | 9.7% | — |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $993.0M | — |
8季度趋势，按日历期对齐
经营现金流AWAL
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $-2.7B | ||
| Q3 25 | $362.0M | $-597.4M | ||
| Q2 25 | $221.0M | $-357.7M | ||
| Q1 25 | $431.0M | $-1.7B | ||
| Q4 24 | $481.0M | $-2.7B | ||
| Q3 24 | $452.0M | $-1.1B | ||
| Q2 24 | $333.0M | $-745.8M |
自由现金流AWAL
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | — | ||
| Q3 25 | $259.0M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $334.0M | — | ||
| Q4 24 | $388.0M | — | ||
| Q3 24 | $360.0M | — | ||
| Q2 24 | $230.0M | — |
自由现金流率AWAL
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 19.9% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 14.6% | — |
资本支出强度AWAL
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 6.5% | — |
现金转化率AWAL
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | -9.36× | ||
| Q3 25 | 1.08× | -2.36× | ||
| Q2 25 | 1.03× | -1.55× | ||
| Q1 25 | 1.36× | -8.31× | ||
| Q4 24 | 1.37× | -12.64× | ||
| Q3 24 | 1.60× | -5.35× | ||
| Q2 24 | 1.08× | -3.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
WAL
暂无分部数据
